TRIANA Biomedicines is developing molecular glue therapeutics initially tailored for targeted protein degradation applications. TRIANA is building its pipeline using a target-first, rational approach to molecular glue discovery, and aspires to develop products for a wide range of therapeutic applications.
| Headquarters | Waltham, MA |
| Website | trianabio.com |
| Pipeline | Preclinical |
| @Triana_Bio | |
| TRIANA Biomedicines |